-
Credit Suisse stated that CMS (00867.HK)  -0.080 (-0.556%)    Short selling $1.31M; Ratio 1.993%   increased approximately 18% share capital in Tibet Pharma (600211.SH) at a cash consideration of RMB 785 million.

Credit Suisse lifted the target price of CMS from $12.83 to $15. However, since the stock is already trading at a premium to R&D-oriented pharma companies and the potential of the two new drugs was largely reflected in the share price, the rating of CMS was downgraded from Outperform to Neutral.

Comments

Post a Comment

Popular posts from this blog

-
CLSA lowers Beijing Ent Water (00371) to HK$6   CLSA cut its target price for Beijing Enterprises Water (BEW)(00371) by 8% to HK$6, and reiterated its "buy" rating.   The research house said BEW's share price has dropped 14% in the last two trading days. First, the 2017 earnings results are below expectations. Second, management is guiding for 20-25% net profit growth for 2018, versus 30% in the past few years. Management now has a cautious approach to water PPP (public-private partnership) projects, which is not  necessarily bad.   CLSA cut its 2018-19 earnings forecasts by 19%. At the current level, it believes many  of the negatives are already priced-in.
Read more
-
Image
WKK INTL (HOLD) (00532.HK)    +0.100 (+15.152%)      announced the results for its subsidiary, Taiwan Kong King, for the nine months ended September 2014. The unaudited combined after-tax net profit decreased 30.26% to $12.239 million, compared with the same period last year. Revenue amounted to $177 million.
Read more
-
]Daiwa lifts Anta Sports (02020) to HK$43.5   Daiwa Research lifted its target price for Anta Sports Products (02020) to HK$43.5 from HK$40, and reiterated its "buy" rating.   The research house said Anta's 2017 earnings growth of 29.4% YoY to CNY3.1bn was in line with Daiwa's expectations. However, its results were mixed, with government grants and FX gains offsetting weaker-than-expected margins.   Nevertheless, Daiwa remains confident in the company's multi-brand and omni-channel strategy. It raised its revenue assumptions for 2018-19 to account for the recent revenue growth momentum and inclusion of the group's new brands, but trimmed its gross and  operating margin estimates on higher raw material, A&P, staff and rental cost assumptions. In all, Daiwa trimmed 2018 earnings and raised its 2019 earnings by less than 1%. 
Read more